Business Wire

Sengenics Strengthens Strategy to Enable Wider Access to Patented Protein Microarray Technology with the Launch of the Sengenics i-Ome® Protein Array Kit

BOSTON--(BUSINESS WIRE)--Sengenics today announced the commercial launch of the i-Ome® Protein Array Kit. The i-Ome® Protein Array Kit contains slide-based, high density protein microarrays, comprised ...
GEN

Protein Microarrays

As protein arrays have become increasingly consistent and reliable, more scientists have begun to incorporate them into their proteomics experiments. Researchers are attracted by the technology’s ...
GEN

Protein Microarray Market Scope Broadens

Focused Protein Profiling Strategies and Reverse-phase Arrays Drive Growth Multiplexed protein measurements using protein microarrays have several promising applications in drug discovery and clinical ...
Nature

A protein microarray

The sequencing phase of the human genome project is now near completion, but then what? An even harder challenge remains — to identify the structures and functions of all proteins encoded in the ...
Nature

Recombinant antibody microarrays—a viable option?

One means of addressing this problem is to design a recombinant antibody library on the basis of a single framework, such as one based on single-chain Fv (scFv) fragments 8. As all scFvs in such a ...